Financhill
Back

Curaleaf Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
45

CURLF
Curaleaf Holdings

Last Price:
4.09
Seasonality Move:
9.41%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
40.85
Seasonality Move:
-0.9%
Sell
45
Curaleaf Holdings (CURLF) is a Sell

Is Curaleaf Holdings a Buy, Sell or Hold?

  • The current Curaleaf Holdings [CURLF] share price is $4.27. The Score for CURLF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CURLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CURLF Stock Price Chart

What is Curaleaf Holdings's stock price today?

  • The Curaleaf Holdings share price today is $4.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CURLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CURLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 44.67 Sell
Chaikin Money Flow: 625944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.08 - 4.66) Sell
Bollinger Bands (100): (4.41 - 5.47) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

CURLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.05 Buy
20-day SMA: 4.28 Sell
50-day SMA: 4.87 Sell
200-day SMA: 4.5 Sell
8-day EMA: 4.13 Buy
20-day EMA: 4.31 Sell
50-day EMA: 4.65 Sell
200-day EMA: 4.56 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Curaleaf Holdings Earnings Growth & CURLF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Curaleaf Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):